Breast Cancer ER PR HER2 Ki67 Test
Introduction to the Test
The Breast Cancer ER PR HER2 Ki67 test is an advanced diagnostic procedure that plays a pivotal role in the management of breast cancer. This test evaluates the expression of hormone receptors (Estrogen Receptor (ER), Progesterone Receptor (PR)) and the HER2 protein, along with the Ki67 proliferation index. Understanding these markers is essential for determining the most effective treatment strategy for patients diagnosed with breast cancer.
What the Test Measures
This test assesses the following components:
- ER (Estrogen Receptor): Indicates the presence of estrogen receptors in cancer cells.
- PR (Progesterone Receptor): Indicates the presence of progesterone receptors in cancer cells.
- HER-2: Measures the overexpression of the HER2 protein.
- Ki-67: A marker that indicates cell proliferation.
Who Should Consider This Test?
This test is recommended for individuals who exhibit symptoms or possess risk factors for breast cancer, including:
- Family history of breast cancer
- Presence of breast lumps or changes
- Previous abnormal mammogram results
Benefits of Taking the Test
The Breast Cancer ER PR HER2 Ki67 test provides several benefits, including:
- Guiding treatment decisions based on receptor status.
- Helping to predict the aggressiveness of the cancer.
- Assisting oncologists in personalizing therapy for better outcomes.
Understanding Your Results
Interpreting the results of the Breast Cancer ER PR HER2 Ki67 test requires a thorough understanding of the receptor status:
- Positive ER/PR status often indicates that hormone therapy may be effective.
- HER2 positive tumors may respond to targeted therapies.
- A high Ki67 index suggests a more aggressive cancer that may require intensive treatment.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Breast Cancer ER PR HER2 Ki67 | 280,000 NGN | 400,000 NGN |
Booking the Test
To book the Breast Cancer ER PR HER2 Ki67 test, please contact us at DNA Labs Nigeria. Our team is ready to assist you with the booking process.
For inquiries and bookings, call or WhatsApp us at +2348077798758.
Pre-Test Instructions
Before undergoing the test, please provide a copy of the Histopathology report, clinical history, and indicate the site of biopsy. The sample type required is either tumor tissue in 10% Formal-saline or a Formalin fixed paraffin embedded block, which should be shipped at room temperature.
Turnaround Time
The results of the Breast Cancer ER PR HER2 Ki67 test will be available within 10 days.
Specialty and Method
This test is conducted under the specialty of Oncology in the Histology department using the Immunohistochemistry method, focusing on cancer diagnostics.
